Literature DB >> 4629910

Accelerated cellular uptake and metabolism of L-thyroxine during acute Salmonella typhimurium sepsis.

F R DeRubertis, K A Woeber.   

Abstract

The effects of acute Salmonella typhimurium sepsis on the kinetics of peripheral L-thyroxine (T(4)) distribution and metabolism and on serum total and free T(4) concentrations were studied in rhesus monkeys inoculated i.v. with either heat-killed or viable organisms. The rate of disappearance of labeled T(4) from serum was increased within 8 h after inoculation of monkeys with either heat-killed or viable Salmonella. The effects of the heat-killed organisms were transient and no longer evident by 16 h postinoculation. The monkeys inoculated with the viable Salmonella experienced a 2-3 day febrile, septic illness that was accompanied by an increase in the absolute rate of T(4) disposal. In the infected monkeys, serum total T(4) and endogenously labeled protein-bound iodine concentrations fell significantly during the period of acute sepsis and then rose during convalescence to values that exceeded the preinoculation values, suggesting that thyroidal secretion of hormone had increased in response to a primary depletion of the peripheral hormonal pool. Total cellular and hepatic uptakes of T(4) were enhanced by 4 h after inoculation of monkeys with either heat-killed or viable Salmonella, but the increase in total cellular uptake persisted for 24 h only in the monkeys inoculated with the viable organisms. These alterations in T(4) kinetics could neither be correlated with changes in the binding of T(4) in plasma nor attributed to an increase in vascular permeability. Moreover, they could not be ascribed to an in vitro product of bacterial growth, suggesting that the presence of the organisms themselves was required. An acceleration of T(4) disappearance was also observed during Escherichia coli and Diplococcus pucumoniae bacteremias. Our findings are consistent with a primary increase in the cellular uptake and metabolism of T(4) during bacterial sepsis, possibly related to phagocytic cell function in the host.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4629910      PMCID: PMC302229          DOI: 10.1172/JCI107176

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  THE EFFECTS OF NONCALORIGENIC CONGENERS OF SALICYLATE ON THE PERIPHERAL METABOLISM OF THYROXINE.

Authors:  K A WOEBER; S H INGBAR
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  ROLE OF PEROXIDASE AND CATALASE IN THE PHYSIOLOGICAL DEIODINATION OF THYROXINE.

Authors:  V A GALTON; S H INGBAR
Journal:  Endocrinology       Date:  1963-11       Impact factor: 4.736

3.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever.

Authors:  J G WISWELL; V CORONHO
Journal:  J Clin Endocrinol Metab       Date:  1962-06       Impact factor: 5.958

4.  Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.

Authors:  S H INGBAR; N FREINKEL
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

5.  Thyroxine turnover and transport in active acromegaly.

Authors:  M Inada; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

6.  Effect of exercise on thyroxine degradation in athletes and non-athletes.

Authors:  C H Irvine
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

7.  Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

Authors:  J H Oppenheimer; G Bernstein; J Hasen
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

8.  Evidence for enhanced cellular uptake and binding of thyroxine in vivo during acute infection with Diplococcus pneumoniae.

Authors:  F R DeRubertis; K A Woeber
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

9.  Function of h(2)o(2), myeloperoxidase, and hexose monophosphate shunt enzymes in phagocytizing cells from different species.

Authors:  B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

10.  Iodination of bacteria: a bactericidal mechanism.

Authors:  S J Klebanoff
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  5 in total

1.  Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection.

Authors:  Ohad Gal-Mor; Jotham Suez; Dana Elhadad; Steffen Porwollik; Eyal Leshem; Lea Valinsky; Michael McClelland; Eliezer Schwartz; Galia Rahav
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

2.  Studies on the possible role of thyroid hormone in altered muscle protein turnover during sepsis.

Authors:  P O Hasselgren; I W Chen; J H James; M Sperling; B W Warner; J E Fischer
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

3.  Extracellular metabolism of thyroid hormones by stimulated granulocytes.

Authors:  M K Rao; A L Sagone
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  SalmoNet, an integrated network of ten Salmonella enterica strains reveals common and distinct pathways to host adaptation.

Authors:  Aline Métris; Padhmanand Sudhakar; David Fazekas; Amanda Demeter; Eszter Ari; Marton Olbei; Priscilla Branchu; Rob A Kingsley; Jozsef Baranyi; Tamas Korcsmáros
Journal:  NPJ Syst Biol Appl       Date:  2017-10-18

5.  Exclusive dependence of IL-10Rα signalling on intestinal microbiota homeostasis and control of whipworm infection.

Authors:  María A Duque-Correa; Natasha A Karp; Catherine McCarthy; Simon Forman; David Goulding; Geetha Sankaranarayanan; Timothy P Jenkins; Adam J Reid; Emma L Cambridge; Carmen Ballesteros Reviriego; Werner Müller; Cinzia Cantacessi; Gordon Dougan; Richard K Grencis; Matthew Berriman
Journal:  PLoS Pathog       Date:  2019-01-14       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.